- Home
- TNGX vs BLZE Comparison
TNGX vs BLZE Comparison
Compare TNGX & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BLZE
- Stock Information
- Founded
- TNGX 2014
- BLZE 2007
- Country
- TNGX United States
- BLZE United States
- Employees
- TNGX N/A
- BLZE N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BLZE Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- BLZE Technology
- Exchange
- TNGX Nasdaq
- BLZE Nasdaq
- Market Cap
- TNGX 248.2M
- BLZE 252.4M
- IPO Year
- TNGX N/A
- BLZE 2021
- Fundamental
- Price
- TNGX $2.49
- BLZE $5.79
- Analyst Decision
- TNGX Strong Buy
- BLZE Strong Buy
- Analyst Count
- TNGX 6
- BLZE 6
- Target Price
- TNGX $12.20
- BLZE $10.83
- AVG Volume (30 Days)
- TNGX 3.5M
- BLZE 518.4K
- Earning Date
- TNGX 05-12-2025
- BLZE 05-07-2025
- Dividend Yield
- TNGX N/A
- BLZE N/A
- EPS Growth
- TNGX N/A
- BLZE N/A
- EPS
- TNGX N/A
- BLZE N/A
- Revenue
- TNGX $40,990,000.00
- BLZE $132,273,000.00
- Revenue This Year
- TNGX N/A
- BLZE $15.55
- Revenue Next Year
- TNGX N/A
- BLZE $14.48
- P/E Ratio
- TNGX N/A
- BLZE N/A
- Revenue Growth
- TNGX 10.09
- BLZE 21.81
- 52 Week Low
- TNGX $1.03
- BLZE $3.94
- 52 Week High
- TNGX $12.02
- BLZE $8.08
- Technical
- Relative Strength Index (RSI)
- TNGX 62.72
- BLZE 59.80
- Support Level
- TNGX $1.93
- BLZE $5.52
- Resistance Level
- TNGX $2.67
- BLZE $6.05
- Average True Range (ATR)
- TNGX 0.39
- BLZE 0.30
- MACD
- TNGX 0.07
- BLZE 0.03
- Stochastic Oscillator
- TNGX 55.38
- BLZE 54.50
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.